{"id":68758,"date":"2026-02-21T13:56:34","date_gmt":"2026-02-21T13:56:34","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=68758"},"modified":"2026-10-15T10:34:00","modified_gmt":"2026-10-15T10:34:00","slug":"tb-500","status":"publish","type":"product","link":"https:\/\/medsbase.com\/pt-pt\/product\/tb-500\/","title":{"rendered":"TB-500 (Thymosin Beta-4)"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Resposta R\u00e1pida \u2014 O que \u00e9 TB-500?<\/h3>\n<p style=\"margin: 0;\"><strong>TB-500<\/strong> \u00e9 um an\u00e1logo sint\u00e9tico de <strong>Timosina Beta-4<\/strong>, a naturally occurring 43-amino-acid peptide with systemic healing activity. In published preclinical studies it binds G-actin, stimulates angiogenesis via the VEGF\/KDR pathway, and modulates TGF-beta inflammatory signaling. Supplied in 2\u00a0mg to 10\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>O que obt\u00e9m com a MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/pt-pt\/reviews\/\">de clientes<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Cada encomenda est\u00e1 coberta pela nossa <a href=\"https:\/\/medsbase.com\/pt-pt\/medsbase-re-shipment-assurance-policy\/\"><strong>Pol\u00edtica de Garantia de Reenvio<\/strong><\/a> \u2014 se a sua encomenda n\u00e3o chegar no prazo de 20 dias \u00fateis, reenviamo-la.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Especifica\u00e7\u00e3o<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detalhe<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>N\u00famero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">77591-33-4<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>F\u00f3rmula Molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>212<\/sub>H<sub>350<\/sub>N<sub>56<\/sub>O<sub>78<\/sub>S<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso Molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">~4963 Da (N-acetil Timosina \u03b2-4 (1\u201343))<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Sequ\u00eancia<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">P\u00f3 liofilizado (ou conforme fornecido)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pureza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (HPLC verificado, COA dispon\u00edvel mediante pedido)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Armazenamento<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizado: 2\u20138 \u00b0C (frigor\u00edfico) para stock de trabalho; \u221220 \u00b0C para armazenamento a longo prazo de frascos n\u00e3o abertos. Reconstitu\u00eddo: 2\u20138 \u00b0C, utilizar dentro de ~30 dias. Evitar agita\u00e7\u00e3o vigorosa; p\u00e9ptidos grandes desnaturam-se com agita\u00e7\u00e3o. N\u00e3o congelar-descongelar a solu\u00e7\u00e3o reconstitu\u00edda.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilidade<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u00c1gua bacteriost\u00e1tica (recomendada) ou \u00e1gua est\u00e9ril para per\u00edodos de utiliza\u00e7\u00e3o mais curtos<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>O que \u00e9 o TB-500?<\/h2>\n<p><strong>TB-500<\/strong> is the clinical designation for a synthetic analog of <strong>Timosina Beta-4 (TB4)<\/strong>, a naturally-occurring 43-amino-acid peptide hormone found in nearly every cell of the human body. TB4 is most abundant in platelets, and is released at sites of tissue damage where it orchestrates cell migration, angiogenesis, and anti-inflammatory signaling. The synthetic form \u2014 TB-500 \u2014 reproduces the biological activity of TB4 and is the most widely studied compound in this class. The TB4 sequence is <em>Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES<\/em>, molecular weight approximately 4,963\u00a0Da. It is supplied as a high-purity lyophilized powder for reconstitution with bacteriostatic water. For mechanism, published trial detail, and dosing considerations, see our full <a href=\"https:\/\/medsbase.com\/pt-pt\/tb-500-thymosin-beta-4-peptide-guide\/\">TB-500 guide<\/a>. <\/p>\n<h2>Mecanismo de A\u00e7\u00e3o \u2014 Cicatriza\u00e7\u00e3o Sist\u00e9mica atrav\u00e9s de Tr\u00eas Vias<\/h2>\n<p>O TB-500 distingue-se da maioria dos p\u00e9ptidos pela sua <strong>distribui\u00e7\u00e3o sist\u00e9mica e meia-vida longa em circula\u00e7\u00e3o<\/strong>, which allow a single administration to influence repair processes across multiple tissues simultaneously. The three primary mechanistic pathways in published studies:<\/p>\n<ul>\n<li><strong>sequestro de G-actina<\/strong> \u2014 TB-500 binds monomeric actin (G-actin) via a central actin-binding motif (LKKTETQ). This preserves the cytoskeletal reservoir cells need to extend pseudopodia, migrate toward injury sites, and remodel after damage. Cell-migration assays in wound-edge studies consistently show enhanced migration rates in TB4-treated cells.<\/li>\n<li><strong>Angiog\u00e9nese via sinaliza\u00e7\u00e3o VEGF\/KDR<\/strong> \u2014 TB-500 stimulates vascular endothelial migration and capillary formation through the VEGF receptor 2 (KDR) pathway. In ischemia-reperfusion and wound-healing studies this translates to faster restoration of perfusion at repair sites.<\/li>\n<li><strong>Sinaliza\u00e7\u00e3o anti-inflamat\u00f3ria via modula\u00e7\u00e3o de TGF-beta<\/strong> \u2014 TB-500 reduces pro-inflammatory cytokine release and accelerates resolution of the inflammatory phase of healing. In cardiac ischemia studies, this has been linked to reduced infarct size and preserved cardiomyocyte function.<\/li>\n<\/ul>\n<p>Como estes tr\u00eas mecanismos se distribuem por todo o corpo, o TB-500 produz efeitos em tecidos distantes do local de inje\u00e7\u00e3o \u2014 a caracter\u00edstica que o distingue de p\u00e9ptidos de cicatriza\u00e7\u00e3o mais localizados, tais como <a href=\"https:\/\/medsbase.com\/pt-pt\/bpc-157\/\">BPC-157<\/a>. The practical consequence: TB-500 protocols are dosed twice weekly rather than daily. <\/p>\n<h2>Published Evidence<\/h2>\n<p>TB-500 is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Repara\u00e7\u00e3o do m\u00fasculo esquel\u00e9tico<\/strong> \u2014 cin\u00e9tica de recupera\u00e7\u00e3o sist\u00e9mica em modelos de roedores com esmagamento, distens\u00e3o e atrofia por desuso<\/li>\n<li><strong>Cardiac recovery<\/strong> \u2014 sobreviv\u00eancia de cardiomi\u00f3citos, tamanho do enfarte e remodela\u00e7\u00e3o vascular p\u00f3s-isquemia (Smart et al., Nature 2011; Bock-Marquette et al., Nature 2004)<\/li>\n<li><strong>Cicatriza\u00e7\u00e3o de tend\u00f5es e ligamentos<\/strong> \u2014 isolado ou em combina\u00e7\u00e3o com <a href=\"https:\/\/medsbase.com\/pt-pt\/bpc-157\/\">BPC-157<\/a> in connective-tissue repair studies<\/li>\n<li><strong>Repara\u00e7\u00e3o sist\u00e9mica de feridas<\/strong> \u2014 dermal and corneal wound-healing studies, especially where multiple tissue beds are affected<\/li>\n<li><strong>Hair cycle studies<\/strong> \u2014 follicular angiogenesis and hair-growth phase transitions in rodent study models<\/li>\n<li><strong>Repara\u00e7\u00e3o vascular<\/strong> \u2014 endothelial cell migration, capillary formation, and ischemia studies<\/li>\n<li><strong>Comparative peptide studies<\/strong> \u2014 compara\u00e7\u00e3o com o BPC-157 como o comparador can\u00f3nico de cicatriza\u00e7\u00e3o local, ou com <a href=\"https:\/\/medsbase.com\/pt-pt\/igf-1-lr3-peptide-guide\/\">IGF-1 LR3<\/a> e <a href=\"https:\/\/medsbase.com\/pt-pt\/ipamorelin-cjc-1295-stack-guide\/\">Ipamorelin\/CJC-1295<\/a> in growth-factor studies. See our <a href=\"https:\/\/medsbase.com\/pt-pt\/bpc-157-vs-tb-500-comparison-guide\/\">Compara\u00e7\u00e3o entre BPC-157 e TB-500<\/a> para uma compara\u00e7\u00e3o lado a lado.<\/li>\n<\/ul>\n<p>Para um contexto mais amplo sobre onde o TB-500 se enquadra no panorama dos p\u00e9ptidos de cicatriza\u00e7\u00e3o, consulte <a href=\"https:\/\/medsbase.com\/pt-pt\/best-peptides-for-muscle-recovery\/\">os melhores p\u00e9ptidos para recupera\u00e7\u00e3o muscular<\/a> cluster article and complementary compounds in the <a href=\"https:\/\/medsbase.com\/pt-pt\/peptides\/\">cat\u00e1logo de p\u00e9ptidos<\/a>. <\/p>\n<h2>For\u00e7as e Concentra\u00e7\u00f5es Dispon\u00edveis<\/h2>\n<p>A MedsBase disp\u00f5e de TB-500 (Thymosin Beta-4 sint\u00e9tico) nos seguintes tamanhos de frascos liofilizados. Cada varia\u00e7\u00e3o \u00e9 enviada em embalagens de 10, 20 ou 30 frascos com orienta\u00e7\u00f5es completas de reconstitui\u00e7\u00e3o:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">For\u00e7a do frasco<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caso de uso t\u00edpico<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tamanhos das embalagens<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>2\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Pilot studies, titration, or short protocols<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength, matches common 2\u20132.5\u00a0mg dose-per-administration protocols<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Extended studies, bulk prep, lowest per-mg cost<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>All three strengths are the same chemical form (lyophilized powder, 99%+ HPLC purity). Higher-mg vials offer lower per-mg cost and are generally preferred when users are modeling the 2\u20132.5\u00a0mg per-administration dose used across most published TB-500 protocols. <\/p>\n<h2>Como Compara \u2014 TB-500 vs BPC-157<\/h2>\n<p>O TB-500 e o <a href=\"https:\/\/medsbase.com\/pt-pt\/bpc-157\/\">BPC-157<\/a> are the two most-cited healing peptides. They are often studied together because their mechanisms are complementary rather than overlapping \u2014 BPC-157 acts locally via growth-factor upregulation, TB-500 acts systemically via actin and angiogenesis pathways. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Crit\u00e9rio<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">TB-500 (Thymosin Beta-4)<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">BPC-157<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Comprimento<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">43 amino\u00e1cidos (~4,963 Da)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">15 amino\u00e1cidos (~1,419 Da)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Mecanismo prim\u00e1rio<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Sequestro de G-actina, angiog\u00e9nese, TGF-beta<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">VEGF + NO + regula\u00e7\u00e3o positiva do recetor de GH<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Distribui\u00e7\u00e3o<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Sist\u00e9mico, distribui-se amplamente<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Mais localizado no local da inje\u00e7\u00e3o<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Dose t\u00edpica<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">2\u20132,5 mg duas vezes por semana, 4\u20136 semanas de carga<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">250\u2013500 mcg, 1\u20132 vezes por dia<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Strongest signal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Card\u00edaco, m\u00fasculo sist\u00e9mico, vascular, cabelo<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Tend\u00e3o, ligamento, barreira intestinal<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Empilhamento<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Frequentemente coadministrado com BPC-157<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Frequentemente coadministrado com TB-500<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For the full side-by-side methodological comparison and when users pick one over the other, read <a href=\"https:\/\/medsbase.com\/pt-pt\/bpc-157-vs-tb-500-comparison-guide\/\">BPC-157 vs TB-500: qual o p\u00e9ptido de cura para o seu objetivo de recupera\u00e7\u00e3o<\/a>. <\/p>\n<h2>Armazenamento e Reconstitui\u00e7\u00e3o<\/h2>\n<p><strong>Antes da reconstitui\u00e7\u00e3o:<\/strong> armazene os frascos liofilizados no frigor\u00edfico a 2\u20138 \u00b0C na embalagem original. O TB-500 liofilizado \u00e9 est\u00e1vel nestas condi\u00e7\u00f5es at\u00e9 36 meses. Evite ciclos de congela\u00e7\u00e3o-descongela\u00e7\u00e3o no p\u00f3. <strong>Procedimento de reconstitui\u00e7\u00e3o:<\/strong> injecte \u00e1gua bacteriost\u00e1tica pela parede lateral do frasco do p\u00e9ptido (n\u00e3o diretamente sobre o bolo liofilizado) de acordo com a tabela de dilui\u00e7\u00e3o acima. Agite suavemente \u2014 n\u00e3o <strong>n\u00e3o<\/strong> agite \u2014 e aguarde 5\u201310 minutos para dissolu\u00e7\u00e3o completa. Uma solu\u00e7\u00e3o corretamente reconstitu\u00edda deve ser l\u00edmpida e incolor. <strong>Ap\u00f3s reconstitui\u00e7\u00e3o:<\/strong> armazene refrigerado a 2\u20138 \u00b0C e utilize no prazo de 30 dias para uma estabilidade \u00f3tima. N\u00e3o congele a solu\u00e7\u00e3o reconstitu\u00edda \u2014 os ciclos de congela\u00e7\u00e3o-descongela\u00e7\u00e3o degradam a integridade do p\u00e9ptido. Descarte qualquer frasco que apresente turva\u00e7\u00e3o, precipitado ou descolora\u00e7\u00e3o. <\/p>\n<h2 id=\"faqs\">Perguntas Frequentes<\/h2>\n<h3>What is TB-500 used for in studies?<\/h3>\n<p>TB-500 is used in studies investigating skeletal muscle repair, cardiac recovery, tendon and ligament healing, wound repair, hair-cycle studies, vascular repair, and systemic tissue regeneration. It is <strong>n\u00e3o<\/strong> FDA-approved and is sold here strictly for clinical studies use only. <\/p>\n<h3>Como \u00e9 que o TB-500 difere do BPC-157?<\/h3>\n<p>TB-500 is a 43-amino-acid synthetic analog of Thymosin Beta-4 that acts systemically via G-actin binding, angiogenesis, and TGF-beta signaling. BPC-157 is a 15-amino-acid pentadecapeptide that acts mostly locally via VEGF, nitric oxide, and growth-hormone-receptor pathways. The two are often co-administered in studies because their mechanisms are complementary. <\/p>\n<h3>What is the typical TB-500 dose?<\/h3>\n<p>Os protocolos pr\u00e9-cl\u00ednicos publicados utilizam tipicamente 2\u20132,5 mg por administra\u00e7\u00e3o, administrados duas vezes por semana durante uma fase de carga de 4\u20136 semanas, seguida de uma fase de manuten\u00e7\u00e3o semanal. Um frasco de 5 mg reconstitu\u00eddo com 2,0 mL de \u00e1gua bacteriost\u00e1tica produz 2,5 mg\/mL \u2014 80 unidades numa seringa U-100 fornecem 2 mg. <\/p>\n<h3>O TB-500 \u00e9 aprovado pela FDA?<\/h3>\n<p>No. TB-500 (synthetic Thymosin Beta-4) is not approved by the FDA, EMA, MHRA, or any other regulator for human therapeutic use. <\/p>\n<h3>Como deve ser armazenado o TB-500?<\/h3>\n<p>Frascos liofilizados: refrigerados a 2\u20138\u00a0\u00b0C na embalagem original, est\u00e1veis at\u00e9 36 meses. Solu\u00e7\u00e3o reconstitu\u00edda: refrigerada a 2\u20138\u00a0\u00b0C, utilizar no prazo de 30 dias. N\u00e3o congele a solu\u00e7\u00e3o reconstitu\u00edda \u2014 ciclos de congela\u00e7\u00e3o e descongela\u00e7\u00e3o degradam o pept\u00eddeo. <\/p>\n<h3>Como reconstituir o TB-500?<\/h3>\n<p>Siga o gr\u00e1fico de refer\u00eancia de reconstitui\u00e7\u00e3o acima. Adicione \u00e1gua bacteriost\u00e1tica pela parede lateral do frasco (n\u00e3o diretamente sobre o p\u00f3 liofilizado), agite suavemente e deixe dissolver completamente durante 5\u201310 minutos. N\u00e3o <strong>n\u00e3o<\/strong> agite o frasco. <\/p>\n<h3>Que dosagens est\u00e3o dispon\u00edveis na MedsBase?<\/h3>\n<p>A MedsBase disponibiliza TB-500 em frascos liofilizados de 2 mg, 5 mg e 10 mg. Cada dosagem est\u00e1 dispon\u00edvel em embalagens de 10, 20 ou 30 frascos. Todos os frascos s\u00e3o fornecidos com pureza HPLC superior a 99% e um certificado de an\u00e1lise dispon\u00edvel mediante pedido. <\/p>\n<h3>Can TB-500 and BPC-157 be stacked in studies?<\/h3>\n<p>Yes. TB-500 and BPC-157 are among the most commonly co-administered peptides in preclinical studies. Their mechanisms are complementary (systemic vs local, actin-binding vs growth-factor-upregulation), and combined protocols appear frequently in connective-tissue and muscle recovery. See our <a href=\"https:\/\/medsbase.com\/pt-pt\/bpc-157-vs-tb-500-comparison-guide\/\">guia de compara\u00e7\u00e3o<\/a>. <\/p>\n<h3>Por que o TB-500 \u00e9 administrado com menos frequ\u00eancia do que o BPC-157?<\/h3>\n<p>TB-500 has a longer circulating half-life and distributes systemically, so published studies protocols typically dose twice weekly. BPC-157 is more localized and commonly dosed once or twice daily in the same types of injury-model studies. <\/p>\n<h3>Does TB-500 cause side reported effects?<\/h3>\n<p>Published preclinical studies has reported a reasonable safety profile at typical doses. Published toxicology work has not identified off-target signals at standard doses. <\/p>\n<h3>O TB-500 \u00e9 o mesmo que a Thymosina Beta-4 completa?<\/h3>\n<p>TB-500 is marketed as a synthetic form of Thymosin Beta-4 (TB4). In commercial supply, what is sold as &#8220;TB-500&#8221; is typically the full 43-amino-acid TB4 molecule synthesized chemically. Some literature refers to shorter actin-binding fragments (LKKTETQ) as functional TB4 analogs in narrow contexts, but full-length TB4 is the dominant form. <\/p>\n<h3>Qual \u00e9 a meia-vida do TB-500?<\/h3>\n<p>TB-500 (synthetic Thymosin Beta-4) has an estimated serum half-life of several days in preclinical studies \u2014 significantly longer than most GHRPs and site-specific healing peptides such as BPC-157. This extended half-life supports the less-frequent dosing schedules typically used in T\u03b24 protocols. <\/p>\n<h3>How long does TB-500 take to show effects in preclinical studies?<\/h3>\n<p>Preclinical studies using Thymosin Beta-4 in cardiac, skeletal muscle, and connective tissue models typically observe measurable effects over 2\u20134 week cycles. The systemic distribution and longer half-life compared to site-directed peptides mean TB-500 timelines are generally extended. <\/p>\n<h3>Posso encomendar TB-500 para envio internacional?<\/h3>\n<p>Sim. A MedsBase envia TB-500 para todo o mundo a partir da nossa rede dedicada de envio de pept\u00eddeos. As encomendas apenas de pept\u00eddeos qualificam-se para o nosso servi\u00e7o de envio de pept\u00eddeos independente. Todas as encomendas s\u00e3o enviadas em embalagens com controlo de temperatura e com rastreio completo. <\/p>\n<p class=\"medsbase-bundle-link-2026-05-01\" data-marker=\"mb-bundle-link-peptide-healing-stack\">O TB-500 \u00e9 frequentemente utilizado em conjunto com o BPC-157 \u2014 angiog\u00e9nese (BPC-157) mais repara\u00e7\u00e3o do citoesqueleto (TB-500) proporciona uma recupera\u00e7\u00e3o mais r\u00e1pida e completa dos tecidos moles do que qualquer um dos pept\u00eddeos isoladamente; o nosso <a href=\"\/pt-pt\/peptide-healing-stack\/\">Peptide Healing Stack (BPC-157 5 mg + TB-500 5 mg + \u00e1gua bacteriost\u00e1tica)<\/a> envia o protocolo correspondente numa \u00fanica encomenda.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Recovery and Performance<\/h2>\n<ul>\n<li><a href=\"\/pt-pt\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 tendon, ligament, gut recovery<\/li>\n<li><a href=\"\/pt-pt\/ipamorelin\/\"><strong>Ipamorelin<\/strong><\/a> \u2014 Agonista selectivo de grelina \u2014 pulso de GH limpo sem cortisol\/prolactina<\/li>\n<li><a href=\"\/pt-pt\/cjc-1295-with-dac\/\"><strong>CJC-1295 com DAC<\/strong><\/a> \u2014 An\u00e1logo de GHRH com meia-vida prolongada<\/li>\n<li><a href=\"\/pt-pt\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Copper peptide \u2014 skin and connective tissue regeneration<\/li>\n<li><a href=\"\/pt-pt\/igf-1-lr3\/\"><strong>IGF-1 LR3<\/strong><\/a> \u2014 Long-R3 IGF-1 analog \u2014 anabolic \/ regenerative support<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Leitura Adicional<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Learn the science behind this peptide<\/strong><\/p>\n<p style=\"margin: 0;\">Leia o nosso guia completo baseado em evid\u00eancias: <a href=\"https:\/\/medsbase.com\/pt-pt\/tb-500-thymosin-beta-4-peptide-guide\/\"><strong>TB-500 \u2014 mecanismo, dados de ensaios e perspetivas<\/strong><\/a>. Covers mechanism of action, published study data, typical dosing ranges, reconstitution protocols, stacking considerations, and safety\/contraindication notes.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Suporta a regenera\u00e7\u00e3o celular<br \/>\n\u2705 Melhora a modela\u00e7\u00e3o tecidular<br \/>\n\u2705 Promove a atividade dos fibroblastos<br \/>\n\u2705 Estimula a sinaliza\u00e7\u00e3o angiog\u00e9nica<br \/>\n\u2705 Melhora a estabilidade da matriz extracelular<\/p>\n<p><strong>TB-500<\/strong> cont\u00e9m composto de p\u00e9ptido sint\u00e9tico.<\/p>","protected":false},"featured_media":70987,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5441,5442,5443],"class_list":["post-68758","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-peptide","product_tag-tb-500","product_tag-thymosin-beta-4","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product\/68758","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=68758"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/media\/70987"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=68758"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_brand?post=68758"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_cat?post=68758"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_tag?post=68758"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}